Department of Organic Chemistry, Faculty of Pharmacy, Medical University of Lublin, 4A Chodźki Street, 20-093, Lublin, Poland.
Department of Pharmaceutical Microbiology, Faculty of Pharmacy, Medical University of Lublin, 1 Chodźki Street, 20-093, Lublin, Poland.
Arch Pharm Res. 2018 Jun;41(6):633-645. doi: 10.1007/s12272-018-1025-3. Epub 2018 Apr 4.
This article describes the synthesis and antimicrobial activity evaluation of new pipemidic acid derivatives. New compounds were obtained on the basis of Mannich reaction of 4,5-disubstituted 1,2,4-triazole-3-thiones with pipemidic acid. Antimicrobial tests revealed high antibacterial activity of obtained derivatives. Gram-negative rods belonging to Enterobacteriaceae family were particularly most sensitive to new pipemidic acid derivatives. Synthesized compounds exhibited very strong activity towards Proteus mirabilis ATCC 12453, Salmonella typhimurium ATCC 14028 and Escherichia coli ATCC 25922. The minimum inhibitory concentrations of new pipemidic acid derivatives which inhibited the growth of these bacteria were 0.98-7.81 µg/ml, 0.98-7.81 µg/ml and 0.98-3.91 µg/ml, respectively. The antibacterial activity of newly synthesized pipemidic acid derivatives in many cases was far better than the activity of substances used as positive controls (nitrofurantoin, cefuroxime, ampicillin and pipemidic acid).
本文描述了新型哌拉西林酸衍生物的合成及抗菌活性评价。新化合物是通过 4,5-二取代 1,2,4-三唑-3-硫酮与哌拉西林酸的曼尼希反应得到的。抗菌试验显示所得到的衍生物具有很高的抗菌活性。属于肠杆菌科的革兰氏阴性杆菌对新型哌拉西林酸衍生物特别敏感。合成的化合物对奇异变形杆菌 ATCC 12453、鼠伤寒沙门氏菌 ATCC 14028 和大肠杆菌 ATCC 25922 表现出很强的活性。抑制这些细菌生长的新型哌拉西林酸衍生物的最小抑菌浓度分别为 0.98-7.81μg/ml、0.98-7.81μg/ml 和 0.98-3.91μg/ml。在许多情况下,新合成的哌拉西林酸衍生物的抗菌活性远远优于用作阳性对照的物质(呋喃妥因、头孢呋辛、氨苄西林和哌拉西林酸)的活性。